Research & Publications
Georgia Charkoftaki received her pharmacy degree from the University of Athens, Greece, where she also earned a MSC in drug delivery and a PhD in biopharmaceutics-pharmacokinetics. In August 2013 she moved to the University Colorado Denver to start a postdoc in clinical and translational science, focusing on kidney related diseases. Charkoftaki studied the pharmacokinetics of cyclophosphamide in patients undergoing dialysis and how Vitamin D affects drug metabolism in the kidneys, among other projects. At Yale she has focused on metabolomics working with Waters Xevo G2 QTof and molecular biology. Her main project is a study the importance of aldehyde dehydrogenases (ALDHs) on cancer and diabetes and the discovery of new potential drug targets.